Rationale for combination therapy in age-related macular degeneration

Retina

Volumn 29, Issue SUPPL. 6, 2009, Pages

  Spaide, Richard F ^a  

^a VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

Author keywords

Angiogenesis; Choroidal neovascularization; Combination therapy; Inflammation; Normalization

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CYTOKINE; PLATELET DERIVED GROWTH FACTOR; TRASTUZUMAB; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

BLOOD VESSEL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; IONIZING RADIATION; MESENCHYME CELL; MONOTHERAPY; NOTE; PERICYTE; PROTEIN PROTEIN INTERACTION; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

AGED; ANGIOGENESIS INHIBITORS; CHOROIDAL NEOVASCULARIZATION; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; MACULAR DEGENERATION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68049148382     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181ad237a     Document Type: Note

References (10)

1. Spaide RF. Rationale for combination therapies for choroidal neovascularization. Am J Ophthalmol 2006;141:149-156. (Pubitemid 43016187)
2. Spaide RF. Combination therapies for choroidal neovascularization. In: Holz FG, Spaide RF, eds. Medical Retina (Essentials in Ophthalmology). Heidelberg: Springer; 2007:90-104.
3. Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1999;40:1891-1898. (Pubitemid 29365148)
4. Grossniklaus HE, Ling JX, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 2002;8:119-126.
5. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004;113:1040-1050. (Pubitemid 38544126)
6. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005;307:58-62.
7. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 2003;111:1287-1295. (Pubitemid 36554699)
8. Schmid MC, Varner JA. Chapter 15. Methods to study myeloid cell roles in angiogenesis. Methods Enzymol 2008;445:343-371.
9. Allavena P, Sica A, Garlanda C, Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 2008;222:155-161.
10. Saccani A, Schioppa T, Porta C, et al. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 2006;66:11432-11440. (Pubitemid 46009975)